Literature DB >> 25889135

Antifungal therapy for onychomycosis in children.

Stephanie Feldstein1, Christine Totri1, Sheila Fallon Friedlander2.   

Abstract

Onychomycosis is a chronic infection of the nail unit, and its prevalence increases with age. Treatment options for children are similar to those for adults and include both oral and topical therapies. Oral agents, such as terbinafine, itraconazole, and fluconazole have been reported to have good efficacy and a low rate of side effects in children. Topical therapies, such as amorolfine and ciclopirox, can also be used as monotherapy or combined with oral agents to treat onychomycosis. Due to their thinner, faster-growing nails, children are more likely to respond to topical monotherapy than adults. There is currently insufficient data comparing emerging medical devices, such as laser therapy, with standard therapeutic options to recommend their use in children.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25889135     DOI: 10.1016/j.clindermatol.2014.12.010

Source DB:  PubMed          Journal:  Clin Dermatol        ISSN: 0738-081X            Impact factor:   3.541


  5 in total

Review 1.  Variability in Systemic Treatment Efficacy for Onychomycosis: Information That Clinical Studies Do Not Impart to the Office Dermatologist.

Authors:  Avner Shemer; Ralph Daniel; Dimitris Rigopoulos; Renata Farhi; Meir Babaev
Journal:  Skin Appendage Disord       Date:  2017-10-26

2.  An investigation of how fungal infection influences drug penetration through onychomycosis patient's nail plates.

Authors:  W J McAuley; S A Jones; M J Traynor; S Guesné; S Murdan; M B Brown
Journal:  Eur J Pharm Biopharm       Date:  2016-03-08       Impact factor: 5.571

Review 3.  Onychomycosis: An Updated Review.

Authors:  Alexander K C Leung; Joseph M Lam; Kin F Leong; Kam L Hon; Benjamin Barankin; Amy A M Leung; Alex H C Wong
Journal:  Recent Pat Inflamm Allergy Drug Discov       Date:  2020

4.  Repurposing FDA-approved drugs as therapeutics to treat Rift Valley fever virus infection.

Authors:  Ashwini Benedict; Neha Bansal; Svetlana Senina; Idris Hooper; Lindsay Lundberg; Cynthia de la Fuente; Aarthi Narayanan; Bradford Gutting; Kylene Kehn-Hall
Journal:  Front Microbiol       Date:  2015-07-08       Impact factor: 5.640

Review 5.  Treatment of Dermatophytosis in Elderly, Children, and Pregnant Women.

Authors:  Subuhi Kaul; Savita Yadav; Sunil Dogra
Journal:  Indian Dermatol Online J       Date:  2017 Sep-Oct
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.